产品封面图

CD8免疫组化抗体,Ready-to-use

收藏
  • ¥1475
  • Santa/Abnova/Abcam
  • AD80067
  • USA
  • 2025年07月15日
  • IHC
  • Mouse Monoclonal
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 抗体名

      CD8免疫组化抗体,Ready-to-use

    • 抗体英文名

      CD8 Antibody Mouse Monoclonal

    • 应用范围

      IHC

    • 宿主

      Mouse Monoclonal

    • 供应商

      上海研卉生物科技有限公司

    • 库存

      大量

    • 适应物种

    • 保质期

      一年

    • 是否单克隆

      0

    • 保存条件

      低温

    • 规格

      6ml

    CD8免疫组化抗体,Ready-to-use

    CD8 Antibody

    Mouse Monoclonal Antibody (Mab)

    Product info
    Application
    产品细节图片1
    IHC
    Primary Accession P01732
    Reactivity Human
    Host Mouse
    Clonality Monoclonal
    Isotype IgG1
    Clone Names 457F6F8
    Additional info
    Gene ID 925
    Gene Name CD8A
    Other Names T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2, CD8a, CD8A, MAL
    Dilution IHC~~Ready-to-use
    Storage Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
    Precautions CD8 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.
    Protein Information
    Synonyms MAL
    Function Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class I molecule:peptide complex. The antigens presented by class I peptides are derived from cytosolic proteins while class II derived from extracellular proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of cytotoxic T-lymphocytes (CTLs). This mechanism enables CTLs to recognize and eliminate infected cells and tumor cells. In NK- cells, the presence of CD8A homodimers at the cell surface provides a survival mechanism allowing conjugation and lysis of multiple target cells. CD8A homodimer molecules also promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells.
    Cellular Location Isoform 1: Cell membrane; Single-pass type I membrane protein Note=CD8A localizes to lipid rafts only when associated with its partner CD8B.
    Tissue Location CD8 on thymus-derived T-cells usually consists of a disulfide-linked alpha/CD8A and a beta/CD8B chain. Less frequently, CD8 can be expressed as a CD8A homodimer. A subset of natural killer cells, memory T-cells, intraepithelial lymphocytes, monocytes and dendritic cells expresses CD8A homo-dimers Expressed at the cell surface of plasmacytoid dendritic cells upon herpes simplex virus-1 stimulation.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 只需这四步!多重荧光免疫组化方法建立

      。我们在这里介绍收集到的一些经验和最佳实践,建立可重复的工作流程的四个关键步骤,包括抗体组合开发、染色、图像采集和分析,可节省研究人员的时间,并最终提高药物发现和开发的效率。 1. 建立最佳抗体组合 使用 Opal 多重荧光免疫组化工作流程准确、可重复地鉴定组织中的不同细胞群及其关系,需要仔细设计、开发和优化用于多重生物标志物定量的抗体组合[1]。 a 从预先设计的抗体组合开始 要选择在多重荧光免疫组化中具有高灵敏度、特异性、再现性和优异性能的可识别所需靶标的抗体似乎并不那么容易

    • Nature Cancer I 生物标志物多参数评估mTLS预测实体瘤免疫治疗效果

      TLS 成熟度,需要对 CD8、CD4、CD20、CD21 和 CD23 进行多参数分析。 阻断 PD-1 受体与其主要配体 PD-L1 之间的相互作用具有显著抗癌作用,已有多种抗 PD-1 或抗 PD-L1 药物被批准用于多种实体瘤治疗。然而,大多数接受抗 PD-1 或抗 PD-L1 单克隆抗体的患者并没有从中获益。 免疫组织化学、肿瘤突变负荷 (TMB) 和微卫星不稳定性状态评估的 PD-L1 表达状态是迄今为止唯一被批准用于指导抗 PD-1 治疗的伴随诊断标志物。这些方法并不能有效区分出可能

    • Interferon- ELISPOT Assay for the Quantitative Measurement of Antigen-Specific Murine CD8+ T-Cells

      antigen-specific murine CD8+ T-cells. Spleen cells from specific cytotoxic T-lymphocyte (CTL) peptide-primed mice are used source of CD8+ T-cells to demonstrate the utility of this technique. The assay procedure is facilitated by the use of a ready-to-use

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1813
    上海研卉生物科技有限公司
    2025年07月14日询价
    ¥3885
    北京智杰方远科技有限公司
    2025年07月10日询价
    ¥2831
    上海瑶韵生物科技有限公司
    2025年07月16日询价
    ¥4194
    武汉博欧特生物科技有限公司
    2025年07月09日询价
    ¥1664.40
    深圳欣博盛生物科技有限公司
    2025年07月11日询价
    CD8免疫组化抗体,Ready-to-use
    ¥1475